Singota Solutions (Bloomington, Indiana CDMO) discusses The Advantages Of A Cross-Functional Staff Model In Pharmaceutical Manufacturing. Singota specializes in small batch aseptic filler, aseptic manufacturing solutions (aseptic filling), cold chain pharmaceutical storage, gmp compliant warehouse, and injectable formulation development.
Sitav Elturan Manufacturing

The Advantages Of A Cross-Functional Staff Model In Pharmaceutical Manufacturing

In the world of pharmaceutical manufacturing, Singota Solutions (Bloomington, Indiana CDMO) stands out by leveraging a cross-functional staffing model that spans sampling/dispensing, formulation, filling, and finishing. This approach is complemented by our small batch aseptic filler and comprehensive aseptic manufacturing solutions (including aseptic filling). Employees are cross-trained, allowing them to…
Read More
Singota Solutions (Bloomington, Indiana CDMO) discusses Factors In Developing Injectable Drug Placebo Formulations For Pharmaceutical Clinical Trials. Singota specializes in small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, gmp compliant warehouse, and injectable formulation development.
Sitav Elturan Best Practices, Manufacturing, Testing

Factors in Developing Injectable Drug Placebo Formulations for Pharmaceutical Clinical Trials

In the dynamic landscape of pharmaceutical research, the significance of placebo-controlled trials as a litmus test for evaluating the efficacy of emerging medications cannot be overstated. However, the efficacy of such trials hinges upon a meticulous understanding and implementation of placebo development practices. This article from Singota Solutions (Bloomington, Indiana…
Read More
Singota Solutions (Bloomington, Indiana CDMO) discusses Characterizing Novel Microparticle-Encapsulated Drug Formulations Part 2. Singota specializes in small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, gmp compliant warehouse, injectable formulation development.
Sitav Elturan Manufacturing

Characterizing Novel Microparticle Encapsulated Drug Formulations – Part 2

As the demand for targeted and controlled release therapies continues to rise, microparticle encapsulated drugs emerge as increasingly desirable dosage forms among clinicians. In this second part of our series, we delve deeper into the intricate process of injectable formulation development, focusing on the crucial task of characterizing and understanding…
Read More
Singota Solutions Bloomington Indiana CDMO specializing in aseptic filling, small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, gmp compliant warehouse, injectable formulation development, drug development and formulation development, delves into approaches to aseptic contract manufacturing solutions part 2
Sitav Elturan Aseptic Filling, Best Practices, Manufacturing

Approach To Simplifying Aseptic Contract Manufacturing – Part 2: Documentation

In our ongoing exploration of aseptic manufacturing solutions, this second installment delves deeper into the operational efficiencies brought forth by the Cytiva SA25 Aseptic Filling Workcell, utilized by Singota Solutions (the very first in North America to employ the SA25). This installment focuses on how this state-of-the-art small batch aseptic…
Read More
Singota Solutions (CDMO Bloomington, Indiana) describes approaches to aseptic contract manufacturing, with their expertise in small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, gmp compliant warehouse, and injectable formulation development
Sitav Elturan Aseptic Filling, Manufacturing

Approach To Simplifying Aseptic Contract Manufacturing

Navigating the intricacies of pharmaceutical and biologic clinical trials demands agile supply chain management, especially when facing sudden demands for clinical drug product. In this inaugural piece of our series, we delve into the pivotal role of Contract Development and Manufacturing Organizations like Singota Solutions (Bloomington, Indiana CDMO) in meeting…
Read More
Singota Solutions (Bloomington, Indiana CDMO specializing in small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, gmp compliant warehouse, and injectable formulation development), explores small and early stage partners and batch sizes.
Sitav Elturan Best Practices, Development, Manufacturing

Specializing In Small And Early-Stage Partners, Not Just Small Batches

Navigating a complex landscape, small pharmaceutical firms seek aseptic manufacturing solutions that cater to their specific needs. This is where Singota Solutions (Bloomington, Indiana CDMO) steps in, offering expertise in small batch aseptic filler technologies and specialized capabilities in injectable formulation development. With a focus on bridging the gap for…
Read More
Singota Solutions (CDMO Bloomington, Indiana) details challenges and solutions to biologic therapies in product manufacturing, with expertise in small batch aseptic filler. Singota specializes in small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, gmp compliant warehouse, injectable formulation development.
Sitav Elturan Manufacturing

Challenges and Solutions in Biologic Therapies Product Manufacturing

In the intricate realm of injectable formulation development, crafting effective solutions for biologic therapies demands meticulous attention to detail and innovative approaches. Unlike conventional small molecule products, biologics necessitate specialized small batch aseptic filler techniques (Singota Solution's specialty) tailored to their unique properties and parenteral administration requirements. Formulation scientists and…
Read More
Aseptic Filling CDMO Singota Solutions in Bloomington, Indiana, discusses Specializing In Small And Early-Stage Injectables, Not Just Small Batches. Singota specializes in small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, gmp compliant warehouse, injectable formulation development.
Eric Graban Best Practices, Manufacturing

Specializing In Small And Early-Stage Injectables, Not Just Small Batches

Source: Singota Solutions Navigating the complex landscape of pharmaceutical development (Injectables), particularly for small and early-stage companies, demands careful consideration of manufacturing partnerships. While large CDMOs may seem like obvious choices, their focus on high-volume production often leaves smaller projects sidelined. This shift is notable in the context of the industry's…
Read More
IND Submission DMO Singota Solutions (Bloomington, Indiana), a leader in Sterile Aseptic Filling, discusses Strengthen Your IND Submission To The FDA By Conducting Microbial Challenge Studies. Singota specializes in small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, gmp compliant warehouse, and injectable formulation development.
Michelle Hoover Best Practices, Manufacturing

Strengthen Your IND Submission To The FDA By Conducting Microbial Challenge Studies

Microbial challenge studies are becoming increasingly common as drug products (DP) are being manufactured with different types of active pharmaceutical ingredients (API) than fifteen years ago (IND Submission). Peptides, proteins, monoclonal antibodies, oligonucleotides, and biosimilars are more common; manufacturing no longer places an emphasis on small molecules. These new APIs…
Read More
Batch Manufacturing CDMO Singota Solutions (Bloomington, Indiana), a leading Aseptic Filling provider, discusses Expertise And Efficiency In Small-Volume Batch Manufacturing. Singota specializes in small batch aseptic filler, aseptic manufacturing solutions, cold chain pharmaceutical storage, gmp compliant warehouse, and injectable formulation development.
Jacob Wheeler Manufacturing

Expertise And Efficiency In Small-Volume Batch Manufacturing

Demand for small-volume drug product (DP) batch manufacturing — from formulation to sterile fill/finish — is rising as drugs for precision medicine and large-molecule biologics gain in prominence. However, traditional fill/finish providers may consider small batch sizes as lacking economic feasibility. They may offer only rigid, far-in-the-future manufacturing dates or…
Read More

Posts pagination

1 2